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The Mediator complex regulates transcription by connecting enhancers to promoters. High
Mediator binding density deﬁnes super enhancers, which regulate cell-identity genes and
oncogenes. Protein interactions of Mediator may explain its role in these processes but have
not been identiﬁed comprehensively. Here, we purify Mediator from neural stem cells (NSCs)
and identify 75 protein-protein interaction partners. We identify super enhancers in NSCs
and show that Mediator-interacting chromatin modiﬁers colocalize with Mediator at
enhancers and super enhancers. Transcription factor families with high afﬁnity for Mediator
dominate enhancers and super enhancers and can explain genome-wide Mediator localiza-
tion. We identify E-box transcription factor Tcf4 as a key regulator of NSCs. Tcf4 interacts
with Mediator, colocalizes with Mediator at super enhancers and regulates neurogenic
transcription factor genes with super enhancers and broad H3K4me3 domains. Our data
suggest that high binding-afﬁnity for Mediator is an important organizing feature in the
transcriptional network that determines NSC identity.
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The Mediator complex is a complex of ~30 subunits that isimportant for transcriptional regulation and is conservedfrom yeast to human1–4. The Mediator complex provides
communication between active enhancers and promoters by
interacting with proteins that bind to either of these two classes of
regulatory DNA elements2,3,5. Accordingly, identiﬁed Mediator-
interacting proteins include many transcription factors2,5, RNA
polymerase II (RNApol2) and transcription elongation factors6.
Recently, Mediator content was used to rank enhancers in
embryonic stem cells (ESCs) and enhancers with the highest
Mediator content were postulated as super enhancers (SEs)7, a
class of enhancers that regulates key genes in cell identity and
oncogenes7–9. Related enhancer types such as stretch enhancers
and anti-pause enhancers were described independently10,11.
There is debate on whether SEs act mechanistically different from
typical enhancers12. Arguments in favor of the functional dis-
tinction of SEs is their ability to drive high levels of transcription
and their selective sensitivity to inhibitors of Brd4, a chromatin-
binding protein enriched at SEs9,10,13. Besides Mediator and
Brd4, chromatin modiﬁers such as Ep300 and Kdm1a (LSD1
complex), chromatin remodelers such as Chd7, Brg1 (SWI-SNF
complex) and Chd4 (NuRD complex) and Smc1a (Cohesin
complex) were found to be enriched at SEs8. In a recently pro-
posed model, the constituent enhancers of an SE and their
regulated promoter(s) would group together to form a phase-
separated assembly14. Such an assembly would rely on interac-
tions between transcriptional and chromatin regulators14.
Cell-type speciﬁc master TFs colocalize with Mediator at
SEs7,8. However, evidence for interactions between master TFs
and Mediator, which would underpin their role in recruiting
Mediator to SEs, is scarce. For example, among SE-binding
master TFs Oct4, Sox2 and Nanog (ESCs), Pu.1 (pro-B cells),
MyoD (Myotubes) and C/EBPα (Macrophages)7, Mediator
interactions were only detected in immunoprecipitations of Sox2
and C/EBPα and these were with single Mediator subunits15,16.
Also our understanding of the recruitment of the above chro-
matin modiﬁers to enhancers and SEs and their subsequent
maintenance at high levels at SEs is far from complete. Mediator
was shown to interact with SE-enriched chromatin modiﬁer
Crebbp17 and the Cohesin complex18, suggesting that Mediator
could, in principle, provide an anchoring role at enhancers, SEs
and the proposed phase-separated assemblies.
To investigate the relevance of Mediator interactors in deﬁning
enhancers and SEs, here we describe the puriﬁcation of the
Mediator complex from neural stem cells (NSCs) and identify its
protein–protein interaction partners by mass spectrometry. To
prevent recording interactions that are mediated via DNA/chro-
matin, we purify Mediator from non-treated nuclear extracts,
nuclear extracts treated with nuclease benzonase and nuclear
extracts treated with ethidium bromide to disrupt protein-DNA
interactions and only take interactions with the Mediator com-
plex that are not affected by these treatments. Our resulting
Mediator interactome contains 95 proteins of which 75 have not
been, to the best of our knowledge, previously characterized as
Mediator-interacting proteins. Subsequently, we perform Med-
iator ChIP-seq in NSCs and deﬁne SEs in NSCs by their Mediator
content. Remarkably, we ﬁnd that the three most frequent motifs
in SEs are bound by multiple members of the small set of TFs that
we identify as Mediator interactors in NSCs. We show that one of
these TFs, Tcf4, regulates a set of key NSC transcription factor
genes with SEs and broad H3K4me3 domain-containing pro-
moters. High-Mediator afﬁnity therefore appears an important
characteristic of master TFs. Our Mediator interactome contains
many known enhancer-binding chromatin modiﬁers and we
show that Mediator-interacting chromatin modiﬁers Jmjd1c and
Carm1 bind genome-wide to enhancers and SEs. Together this
suggests that high-Mediator-binding afﬁnity selects proteins that
play important roles in establishing and maintaining enhancers
and SEs to facilitate the regulation of cell identity.
Results
Puriﬁcation of the Mediator complex from neural stem cells.
We generated a mouse neural stem cell line expressing FLAG-
tagged Med15 (F-Med15 NSCs) to enable the puriﬁcation of the
Mediator complex by our FLAG-afﬁnity protocol, which com-
bines high efﬁciency and low background19 and was extensively
validated in the past for accuracy by independent immunopre-
cipitations of endogenous proteins19,20. F-Med15 NSCs and
parental NSCs were grown to large scale and nuclear extracts
prepared (see Methods). We were interested in proteins that can
bind to the Mediator complex relying solely on protein–protein
interactions and not being mediated via chromatin, which may
co-purify with a chromatin-binding factor such as the Mediator
complex. We reasoned that proteins interacting with Mediator by
protein–protein interaction would not show a reduced interaction
efﬁciency when treating the nuclear extract with the DNA–RNA
digesting enzyme Benzonase or with ethidium bromide (EtBr),
which intercalates in the DNA and disrupts protein-DNA inter-
actions, as compared to untreated nuclear extracts (Fig. 1a). The
used nuclear extract preparation procedure21 aims to minimize
the amount of DNA/chromatin in the extract by gently douncing
the nuclei as a method for lysis. Nevertheless, remnants of DNA/
chromatin do get released from the nuclei into the extract
(Fig. 1b, Untreated). Addition of benzonase completely removed
chromatin/DNA from the extract. (Fig. 1b, compare Benzonase to
Untreated). We puriﬁed the Mediator complex by FLAG-afﬁnity
from nuclear extracts treated with Benzonase, with EtBr or not
treated, as well as from parental NSCs as a control. Puriﬁed
Mediator samples and control samples were analyzed by mass
spectrometry to identify the proteins present in these samples.
We selected proteins that were speciﬁc for Mediator samples and
that did not go down in abundance (less than two-fold drop in
emPAI score) when comparing puriﬁcations from nuclear
extracts treated with Benzonase or EtBr, to puriﬁcations from
untreated extracts (see Methods). To be included in our ﬁnal list
of Mediator-interacting proteins (Fig. 1c, Supplementary Data 1),
selected proteins also had to be speciﬁcally present in an inde-
pendent replicate of the Mediator puriﬁcation from Benzonase-
treated nuclear extract (Supplementary Data 1).
A Mediator interactome in neural stem cells. We identiﬁed 122
Med15-interacting proteins from the four FLAG-Med15 pur-
iﬁcations (Fig. 1c, Supplementary Data 1), of which 26 proteins
are core-subunits of the Mediator complex, leaving 96 proteins
that we postulate as Mediator complex-interacting proteins. The
vast majority of these Mediator-interacting proteins, 77 proteins,
were not previously identiﬁed as binding to Mediator (Fig. 1c,
indicated in red). Mediator-interacting proteins may interact with
Mediator directly or via other proteins. A number of well-known
constituents of enhancers such as Ep300, Chd7, LSD1 complex,
NuRD complex and SWI-SNF complex were identiﬁed as inter-
actors of Mediator (Fig. 1c, Supplementary Data 1). Cohesin
subunit Smc1a18 was identiﬁed, whereas Cohesin subunit Smc3
and Cohesin loader Nipbl were observed in three out of four
Mediator puriﬁcations and are therefore not part of the ﬁnal
Mediator interactor list (Supplementary Data 1). Ep300, Crebbp,
Chd7, Kdm1a (LSD1 complex), Chd4 (NuRD complex), Smc1a
(Cohesin) and Brg1 (SWI-SNF complex) were recently shown,
like Mediator, to have higher binding densities at super enhancers
(SEs) in embryonic stem cells, as compared to typical enhancers8.
Other transcriptional activators and repressors interacting with
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Mediator included Ncoa1-2, the COMPASS complex, Integrator
complex, TRRAP complex and N-CoR complex (Fig. 1c). We
identiﬁed histone demethylase Jmjd1c and arginine demethylase
Carm1 as Mediator interactors. Carm1 was recently identiﬁed to
bind Med9 in a high throughput interaction screen22. We inde-
pendently conﬁrmed the interactions of Jmjd1c and Carm1 with
Mediator by reverse co-immunoprecipitations with Carm1 anti-
bodies (Fig. 2a) and Jmjd1c antibodies (Fig. 2b). One prominent
Mediator interactor category is mRNA binding proteins (Fig. 1c).
We ﬁnd that Mediator interacts with alternative splicing reg-
ulators Hnrnpf and Mbnl1 and cleavage and polyadenylation
factors Cpsf1 and Cpsf2. These interactions may facilitate the role
that Mediator plays in regulating alternative splicing and alter-
native cleavage and polyadenylation of pre-mRNAs23.
Mediator has been identiﬁed as a co-activator of many DNA
sequence-speciﬁc transcription factors, often nuclear hormone
receptors2,24,25. We identiﬁed 16 DNA sequence-speciﬁc tran-
scription factors (TFs) of which 14 are novel Mediator
interactors (Fig. 1c). Identiﬁed TFs include NFI TFs Nﬁa and
Nﬁb, Sox2 and E-box TFs Tcf4 and Tcf12. The majority of these
TFs have an important function in the regulation of NSCs
(Fig. 2c). To test whether detected Mediator-interacting TFs are
the highest expressed TFs in NSC, which could explain their
detection by mass spectrometry, we plotted the 16 detected TFs
against the 600 highest expressed TFs (by RNA-seq) in our
NSCs. We ﬁnd that Mediator-interacting TFs are not the highest
expressed TFs in NSCs (Fig. 2d). This suggests that the detection
of our Mediator-interacting TFs is primarily related to their high
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Fig. 1 Mediator complex interactome in neural stem cells. a Schematic representation of Mediator complex puriﬁcations from neural stem cells (NSCs)
expressing Med15-FLAG. Mass spectrometry results of the three conditions were compared to select proteins that do not decrease in abundance upon
treatments as chromatin-independent Mediator complex interactors. IP immunoprecipitation, MS Mass spectrometry. b Agarose gel with DNA from untreated
NSC nuclear extract or nuclear extract treated with Benzonase or Ethidium Bromide, as indicated. DNA size markers (M) are indicated. Source data are provided
as a Source Data ﬁle. c Interactome of the Mediator complex in NSCs. Novel Mediator interaction partners are in red, known Mediator interaction partners are
in grey. Thickness of the edges gives an indication of the relative molar protein quantity observed in the puriﬁed Mediator complex samples
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binding afﬁnity for Mediator, as compared to many other, not
detected, TFs.
Brd4 has been shown to strongly colocalize with Mediator at
enhancers and promoters. Despite our high sensitivity of
detecting Mediator interactors, we did not detect Brd4 in any
of our FLAG-Med15 puriﬁcations (Supplementary Data 1 and
data not shown). We also did not detect Jmjd6 and Nsd3,
functional interaction partners of Brd410,26, in any puriﬁcation.
To validate our FLAG-afﬁnity approach, we also puriﬁed
endogenous Mediator from NSCs by immunoprecipitation with a
Med12 antibody (Supplementary Data 2). We ﬁnd back 60 of the
96 interactors identiﬁed in FLAG-Mediator puriﬁcations, includ-
ing 11 transcription factors. With the lower sensitivity and higher
background generally observed in endogenous IPs, we consider
this number of overlapping Mediator interactors a validation of
our FLAG-Mediator puriﬁcations.
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Fig. 2 Mediator complex interactor validation. a Immunoprecipitation (IP) of Carm1 and Med12 by a Carm1 antibody from NSC nuclear extract. Western
blots are probed with the indicated antibodies. Control IP by rabbit IgG and 5% input are also shown. Source data are provided as a Source Data ﬁle.
b Immunoprecipitation (IP) of Jmjd1c and Med12 by Jmjd1c antibody from NSC nuclear extract. Western blots are probed with the indicated antibodies.
Control IP by rabbit IgG and 5% input are also shown. Source data are provided as a Source Data ﬁle. c Function in neural development of identiﬁed
Mediator-interacting transcription factors in NSCs. References are provided in the Methods. d mRNA levels in NSCs of Mediator-interacting transcription
factors (TFs) and the Top 600 highest expressed TFs in NSCs. The average emPAI scores, a semi-quantitative mass spectrometry-based measure of molar
amounts, in the four Mediator complex puriﬁcations is shown for Mediator–interacting TFs
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In conclusion, we expanded the Mediator interactome with
many transcription-associated factors and our experimental set-
up suggests that these interactions are independent of chromatin.
Mediator-based super enhancers in neural stem cells. High-
Mediator content is a deﬁning feature of so-called super enhan-
cers (SEs)7. SEs have not been deﬁned yet in NSCs. We identiﬁed
SEs in NSCs by ranking NSC enhancers, which were previously
deﬁned by the presence of the H3K27ac mark and Ep30027, by
their Med1 ChIP signal using the ROSE algorithm7,9. Accord-
ingly, we identiﬁed 445 SEs in NSCs and assigned the 9436
remaining enhancers as typical enhancers (Fig. 3a, b, Supple-
mentary Data 3). Transcription factors encoded by genes near top
SEs include Mediator-interactors Nﬁa, Tcf4, Sox2 and Sall3
(Fig. 3b). We ﬁnd that active genes near SEs (SE genes) in NSCs
are, on average, several fold higher expressed than genes near
typical enhancers (Fig. 3c). DNA motif enrichment analysis
revealed that E-box, NFI and SOX motifs were the ﬁrst, second
and third most frequent TF DNA binding motifs in Mediator
peaks, both within typical enhancers and SEs (Fig. 3d). These
motifs were also previously observed in NSC enhancers deﬁned
by H3K27ac and Ep30027. Interestingly, TFs that can bind these
motifs are well represented within the select group of TFs that we
ﬁnd interacting with Mediator, with Tcf4 and Tcf12 binding
E-box motifs, Nﬁa and Nﬁb binding NFI sites and Sox2 binding
SOX sites. In summary, we identiﬁed SEs in NSCs and ﬁnd that
the E-box motif is the most frequently occurring motif in Med-
iator peaks within typical enhancers and SEs in NSCs.
Overlap Mediator and interaction partners outside promoters.
The identiﬁcation of Mediator-binding sites in NSCs allowed us
to probe its genome-wide overlap with identiﬁed Mediator
interaction partners. We ﬁrst focused on Mediator-interacting
transcription factors, which with their sequence-speciﬁc DNA
binding capacity would be candidates for Mediator-recruitment
to the genome. Using published ChIP-seq datasets for TFs Nﬁa
and Nﬁb (combined ChIP-seq; NFI) and Sox227, we found that
binding sites of NFI and Sox2 highly overlap with Mediator-
binding sites outside promoters, including at typical enhancers
and SEs (Fig. 4a). Using our Tcf4 ChIP-seq dataset28, we show
that Tcf4 has an even higher overlap with Mediator outside
promoters, at typical enhancers and at SEs (Fig. 4a), consistent
with the ﬁnding that the E-box is the most frequent TF motif at
Mediator-binding sites in enhancers and SEs in NSCs (Fig. 3d).
The sum of binding sites of Tcf4, Sox2 and NFI (T+ S+N)
covers nearly 80% of all Mediator-binding sites outside
promoters and over 80% of Mediator-binding sites within typical
enhancers and SEs (Fig. 4a). The combined binding sites of
representatives of three TF families that we ﬁnd interacting with
Mediator, could therefore potentially account for nearly all
recruitment of Mediator outside promoters in NSCs. Examples of
the overlap of Mediator with Mediator-interacting TFs are shown
in Fig. 4b and c.
Subsequently, we investigated the overlap of Mediator with
interacting chromatin modiﬁers. We performed ChIP-seq for
identiﬁed Mediator-interactors arginine methylase Carm1 and
H3K9 demethylase Jmjd1c. We found that Carm1 and Jmjd1c
highly overlap with Mediator outside promoters, at enhancers
and at SEs (Fig. 4a). Chromatin remodeler Chd7 is known to bind
enhancers in ES cells29 and indeed overlaps with Mediator at
enhancers and SEs in NSCs (Fig. 4a). As expected, RNApol2 and
its associated Integrator complex30 show a high overlap with
Mediator at promoters (Fig. 4a). Polycomb protein Cbx8 and
insulator protein Ctcf, which we never found interacting with
Mediator, show low genome overlaps with Mediator (Fig. 4a).
Examples of the overlap of Mediator with interacting chromatin
modiﬁers are shown in Fig. 4b and c. As expected, we also ﬁnd
high overlaps between Mediator-interacting TFs and Mediator-
interacting chromatin modiﬁers (Fig. 4d). We conclude that
Mediator shows high binding site overlap at enhancers and SEs
with interacting TFs Tcf4, NFI and Sox2 and with interacting
chromatin modiﬁers Jmjd1c, Carm1 and Chd7.
We tested whether genome recruitment of Mediator depends
on some of its interacting TFs. We performed shRNA-mediated
knock-down for TFs, Tcf4 or Sox2 (Fig. 5a). We selected a
number of enhancers from our ChIP-seq data for Mediator, Tcf4
and Sox2 where Mediator genome binding overlaps with genome
binding by Tcf4 and Sox2. We ﬁnd by Med12 ChIP RT-PCR that
Mediator is indeed highly enriched at the selected sites (Fig. 5b).
Knock-down of Tcf4 signiﬁcantly reduced Mediator binding at all
ﬁve selected sites (Fig. 5c). Knock-down of Sox2 signiﬁcantly
reduced Mediator binding at enhancers 6.7 kb upstream from
Olig1 and 6 kb in Tulp3 (Fig. 5d). We ﬁnd that Mediator
binding at 30 kb downstream of Olig1, 8.6 kb in Klf15 and 6.5 kb
in Jag1 are not signiﬁcantly affected by Sox2 knock-down
(Fig. 5d). We conclude that efﬁcient Mediator recruitment to
individual genomic sites can depend on its interaction partners
Tcf4 or Sox2.
Genes with SEs and broad H3K4me3 promoters in NSCs.
Recently genes with broad H3K4me3 domains at their promoters
were identiﬁed31,32, including in NSCs31. The top 5% of broadest
H3K4me3 domains in promoters (here abbreviated as broad
promoters) associated with cell-identity genes31 and tumour-
suppressor genes32. Mechanistically, broad promoters have
increased rates of transcription elongation and higher transcrip-
tional consistency31,32 and show enhanced DNA looping inter-
actions with SEs33, compared to their typical counterparts. We
found that the complete sets of SE genes and broad promoter
genes in NSCs both have Transcription Regulation as their lead
Gene Ontology (GO) category (Fig. 6a and Supplementary
Data 4). Transcriptional regulator genes within the SE category
showed neurogenesis as the only signiﬁcant GO term, whereas
transcriptional regulator genes within the broad promoter cate-
gory included neurogenesis as one of three signiﬁcant GO terms
(Fig. 6a and Supplementary Data 4). The observed enrichment in
transcriptional regulators acting in neurogenesis is in line with
the association with cell-identity genes that has been postulated
for genes with SEs7,8 or genes with broad promoters31. We ﬁnd
that genes with broad promoters partially overlap with SE-
associated genes in NSCs (Fig. 6b). Genes with SEs and broad
promoters (SE+ Broad) strongly enrich for transcriptional reg-
ulators acting in neurogenesis (Fig. 6b, Supplementary Data 4 and
5). Remarkably, both left-over categories of genes, genes with
broad promoters but without SEs (Broad-SE) and genes with SEs
but without broad promoters (SE-Broad) lose transcriptional
regulators acting in neurogenesis as a GO term, whereas
SE-Broad genes lose Transcriptional Regulation as a GO term
altogether (Fig. 6b, Supplementary Data 4). Indeed, Mediator-
interacting TFs Tcf4, Sox2, Sall3, Nﬁa and Nﬁb, as well as other
well-known neural TFs including Olig1-2, Pou3f1, Pou3f3 and
Npas3 and oncogene Myc have broad promoters and SEs (Sup-
plementary Data 5). We ﬁnd that SE+ Broad genes are, on
average, higher expressed than SE-Broad genes or Broad-SE
genes, even when comparing the top 100 of each category
(Fig. 6c). We conclude that in NSCs, genes with both SEs and
broad H3K4me3 promoters account for the association of the
separate categories of SE genes and broad promoter genes with
transcriptional regulators acting in neurogenesis. Broad pro-
moters and SEs appear to act synergistically to give higher
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typical enhancers and SEs. Motif frequency is indicated as the percentage of all Mediator-binding sites at typical enhancers or SEs that harbour this motif
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Fig. 4 Binding site overlap of Mediator complex and its interactors. a Percentage overlap of genome-wide binding sites of Mediator (Med1) with Mediator-
interactors Tcf4, Sox2, NFI (Nﬁa+Nﬁb), Carm1, Jmjd1c, Chd7, Ep300, Integrator complex (Ints11 subunit), and RNApol2 in NSCs. Cbx8 and Ctcf were not
identiﬁed as Mediator interactors and serve as negative controls. Percentages overlap of binding sites, as determined by ChIP-seq, are indicated. T+ S+N,
sum of the binding sites of Tcf4, Sox2, and NFI. TSS, within 1 kb of a transcription start site. b Overlap of binding sites of Mediator (Med1) with binding sites
of Mediator interactors at the Myc locus in NSCs. ChIP-seq tracks for the indicated proteins and histone modiﬁcations at the Myc gene are shown. TheMyc
SE in the adjacent (inactive) Pvt gene is indicated with a red bar. Range of reads per million per base pair is indicated on the y-axis. Scale bar is indicated.
c Overlap of binding sites of Mediator (Med1) with binding sites of Mediator interactors at the Rad51c locus in NSCs. ChIP-seq tracks for the indicated
proteins and histone modiﬁcations at the Rad51c gene are shown. The Rad51c SEs in the adjacent (inactive) Tex10 gene are indicated with red bars. Range of
reads per million per base pair is indicated on the y-axis. Scale bar is indicated. d Overlap of genome-wide binding sites of Mediator interactors and Cbx8
and Ctcf in NSCs. Percentages overlap of binding sites, as determined by ChIP-seq, are indicated
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expression in NSCs, as compared to genes with only one of these
regulatory elements.
Binding of Mediator and interaction partners at promoters.
We investigated transcriptional regulators binding around pro-
moters of Broad+ SE genes. We found that Broad+ SE genes
had higher and broader promoter signals for H3K4me3, RNA-
pol2 and Integrator than SE-Broad and Broad-SE genes (Fig. 6d).
Mediator complex binding to promoters has not yet been ana-
lyzed genome-wide at broad promoters or genes nearest to SEs.
We found that Mediator has a much higher and broader ChIP
signal at Broad+ SE genes than at SE-Broad, Broad-SE and
typical genes (Fig. 6d). Interestingly, we observed the same for
Mediator interactors T+ S+N, Jmjd1c, Carm1 and Chd7
(Fig. 6d). The shape of Mediator signal tracked closely to that of
its interactors with a shoulder upstream of the TSS and a long tail
into the gene (Fig. 6d). As the SE+ Broad deﬁnition appears to
select for genes with the broadest and highest H3K4me3 signal
(Fig. 6d), we also tested the top 100 SE+ Broad, top 100 SE-
Broad and top 100 Broad-SE genes to have more equal signals.
Indeed top 100 SE+ Broad and top 100 Broad-SE have more
similar H3K4me3 signals (Supplementary Fig. 1a) and showed
more similar signals for Mediator and its interactors at the TSS
and upstream of the TSS. However, Mediator and its interactors
have a higher signal downstream of the TSS in SE+ Broad genes,
as compared to all other categories. Top 100 SE-Broad genes have
a more narrow signal for all these factors (Supplementary Fig. 1a).
The close similarity between the Mediator signal and the signals
of its interactors Tcf4, Sox2, NFI, Jmjd1c, Carm1 and Chd7 is also
apparent at individual broad promoter regions (Fig. 6e and
Supplementary Fig. 1b). Top 100 SE+ Broad promoters have
more RNApol2 and Integrator signal than top 100 Broad-SE and
top 100 SE-Broad promoters (Supplementary Fig. 1a), suggesting
more efﬁcient recruitment of RNApol2 and Integrator as a
potential explanation for their higher expression (Fig. 6c). We
conclude that broad promoters have higher and broader signals
for Mediator that is closely tracked by all its tested interacting
factors.
Tcf4 regulates genes with SEs and broad H3K4me3 promoters.
Tcf4 showed the highest overlap with Mediator at enhancers and
SEs of the tested Mediator-interacting TFs (Fig. 4a) prompting us
to further investigate a possible role of Tcf4 in regulating genes
near SEs. We ﬁnd that Tcf4 content followed Mediator content at
enhancers and SEs (Fig. 7a). To test to what extent Tcf4 regulates
genes with or without SEs and/or broad H3K4me3 promoters, we
used our RNA-seq dataset from RNA isolated 44 h after Tcf4
knock-down or control knock-down in NSCs28. We found that
Tcf4 depletion downregulates nearly two-thirds of all SE+ Broad
genes (Fig. 7b) and also has the strongest downregulating effect
on SE-containing genes (Fig. 7c). Genes without SEs, either
Fig. 5 Mediator genome recruitment upon knock-down of Tcf4 or Sox2.
a Relative mRNA levels of Tcf4 48 h after transfection with pSuper-Tcf4-
shRNA or pSuper-control-shRNA (left panel), Relative mRNA levels of Sox2
46 h after transfection with pSuper-Sox2-shRNA or pSuper-control-shRNA
(right panel). Source data are provided as a Source Data ﬁle. b Mediator
ChIP signal on selected enhancers at the indicated distances from the TSS
of the indicated genes. RT-PCR signals on the indicated genome areas of
Med12 ChIP (Med12) and control rabbit IgG ChIP (IgG) are indicated as
percentage of chromatin input. Amylase (Amy) functions as a negative
control genomic region. S.e.m. is indicated of two independent experiments.
Source data are provided as a Source Data ﬁle. c Mediator ChIP signal at
selected enhancers upon knock-down of Tcf4. Med12 ChIP RT-PCR signals
on the indicated genome areas in NSCs transfected with a plasmid
expressing Tcf4-shRNA are indicated as percentage of the ChIP signal of
NSCs transfected with a plasmid expressing control shRNA. S.e.m. is
indicated of two independent experiments. Signiﬁcance of the difference in
Med12 ChIP signal between Tcf4-depleted NSCs and control NSCs was
assessed by an unpaired Student t-test (*p < 0.05, **p < 0.01). Source data
are provided as a Source Data ﬁle. d Mediator ChIP signal at selected
enhancers upon knock-down of Sox2. Med12 ChIP RT-PCR signals on the
indicated genome areas in NSCs transfected with a plasmid expressing
Sox2-shRNA are indicated as percentage of the ChIP signal of NSCs
transfected with a plasmid expressing control shRNA. S.e.m. is indicated of
two independent experiments. Signiﬁcance of the difference in Med12 ChIP
signal between Sox2-depleted NSCs and control NSCs was assessed by an
unpaired Student t-test (*p < 0.05, **p < 0.01). Source data are provided as
a Source Data ﬁle
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Broad-SE genes or genes with typical enhancers, are signiﬁcantly
less affected by Tcf4 depletion (Fig. 7c). This suggests that Tcf4
predominantly regulates genes via SEs. Indeed, Tcf4 is present on
nearly all SEs of SE+ Broad and SE-Broad genes (Fig. 7d). Tcf4-
bound and activated SE+ Broad genes include 15 transcription
factor genes (Fig. 7e) of which Bahcc1, Hes1, Myc, Nﬁb, Sall1 and
Sall3, Olig2, Thra and Npas3 encode known regulators of neural
progenitors and/or neurogenesis31,34–39. Tcf4 protein has
protein–protein interactions in NSCs with 6 TFs that are part of
this set of Tcf4-activated TF genes, including Nﬁb and Olig228
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(Fig. 7e). This allows for a potential feed-forward circuit (Fig. 7e)
where Tcf4 maintains the expression of its own co-factors, which
then subsequently may aid Tcf4 in the regulation of other target
genes and its own expression. In line with this possibility, NFI
and Olig2 colocalize with Tcf4 and Mediator on SEs in all 15 TF
genes, for example at the Olig2 gene (Fig. 7f), the Sall3 gene and
the Notch1 gene (Supplementary Fig. 2). Tcf4, Mediator, NFI and
Olig2 also colocalize at the SE in the Tcf4 gene itself (Fig. 7g). Nﬁb
expression has the second-best spatial-temporal correlation (0.56
Pearson coefﬁcient) with Tcf4 expression in pre-natal develop-
ment of the mouse brain (out of 1104 genes)40 and the second-
best spatial-temporal correlation (0.90 Pearson coefﬁcient) with
TCF4 in pre-natal human brain development (out of 19700
genes)41, suggesting that a Tcf4-Nﬁb co-regulatory partnership
could be widespread in mammalian brain development.
Discussion
We have expanded the protein–protein interaction network of the
Mediator complex with many proteins and complexes that reside
at enhancers, super enhancers or promoters and thereby estab-
lished the potential of the Mediator complex as a major inter-
action hub at enhancer-promoter assemblies. Mediator binds to
enhancers and promoters in close proximity to many other
proteins. We believed that chromatin-independent
protein–protein interactions of puriﬁed Mediator complex, as
identiﬁed by their detection by mass spectrometry, would be the
best indicator of its recruitment capacity. Despite our stringent
criteria, 20 years of research on the Mediator complex since its
discovery by several labs25,42–44 and progressing high throughput
interaction studies22,45, we ﬁnd that 75 of our 95 identiﬁed
Mediator interactions have not been, to the best of our knowl-
edge, previously characterized.
Identiﬁed Mediator interactors can be broadly divided into
DNA sequence-independent proteins, mostly chromatin modi-
ﬁers, and sequence-speciﬁc transcription factors. The latter
category of Mediator interactors would represent potential
Mediator-recruitment factors. Indeed, NF-kappaB subunit RelA,
one of the two known Mediator interactors among the 16 iden-
tiﬁed transcription factors, recruits Mediator to activate tran-
scription46. Whereas Mediator-interacting transcription factors
would be more speciﬁc for NSCs (see next paragraph), the
Mediator-interacting chromatin modiﬁers and other proteins are
mostly ubiquitously expressed and would have general relevance
for transcriptional regulation. Supporting this suggestion, our
Mediator interactor screen discovered two major enhancer-
binding proteins. We observed and independently conﬁrmed
interactions between Mediator and arginine methylase Carm1
and putative H3K9 demethylase Jmjd1c. Carm1 is a highly stu-
died enzyme and best known in transcriptional regulation as a co-
activator of nuclear receptors and NF-kappaB and was shown to
act at individual promoters47,48. We ﬁnd that Carm1 is a genome-
wide enhancer-binding protein in NSCs that closely colocalizes
with Mediator. Jmjd1c was identiﬁed as a co-activator of the
tumor-inducing fusion gene AML1-ETO and shown to be
recruited by AML1-ETO to target gene promoters where it lowers
the levels of the repressive mark H3K9me249. We show that
Jmjd1c marks enhancers genome-wide in NSCs, together with
Mediator, where it may perform a similar enzymatic role to
maintain enhancer activity.
A recent analysis8 showed that chromatin modiﬁers Brd4,
Ep300, Crebbp, Chd7, SWI-SNF complex, LSD1 complex,
Cohesin complex and NuRD complex colocalize with Mediator at
enhancers and have an increased binding density at SEs, similar
to the Mediator complex. With the exception of Brd4, we ﬁnd all
the above-mentioned chromatin modiﬁers as Mediator inter-
actors, which may suggest that Mediator interaction aids in their
recruitment to enhancers and SEs. The apparent correlation of
having protein–protein interactions with Mediator and coloca-
lising with Mediator on the genome would predict that other
observed Mediator interactors of unknown genomic location also
reside at enhancers or promoters. This remains to be tested.
We performed Mediator ChIP-seq to identify SEs in NSCs. We
ﬁnd that Mediator-deﬁned SEs in NSCs have as their most fre-
quent TF motifs E-box, NFI and SOX, similar to NSC enhancers
in general27. Nﬁa, Nﬁb, Sox2, Tcf4 and Tcf12, which can bind one
of these motifs, are among the small set of 16 TFs that we
identiﬁed as Mediator interactors. This shows a remarkable
synchrony between Mediator-binding TFs and prominent
enhancer motifs in NSCs. Our identiﬁed Mediator-binding TFs
are not the highest expressed TFs in NSCs, suggesting that they
have a higher binding afﬁnity for Mediator than other TFs. The
above set of TFs may therefore deﬁne enhancers and SEs in NSCs
by having high afﬁnity for Mediator and thereby being effective at
recruiting Mediator and its interactors to its binding sites.
Accordingly, we ﬁnd that Tcf4 and Sox2 are required for optimal
Mediator recruitment to some of the tested genomic sites where
the three factors have overlapping binding. This would suggest
Mediator afﬁnity as an important organizing feature in estab-
lishing the enhancer landscape in a given cell type. Indeed, the
sum of the binding sites of Tcf4, Sox2 and Nﬁ represents nearly
all Mediator-binding sites at enhancers, and outside promoters in
general, and can therefore explain genome-wide Mediator
recruitment outside promoters in NSCs.
Relative promoter occupancy of Mediator has not been ana-
lysed genome-wide in higher eukaryotes, to our knowledge. We
ﬁnd that Mediator has higher and especially broader binding
signals at promoters with a broad H3K4me3 signal, a class of
promoters that was recently discovered31,32. Tcf4, Sox2 and Nﬁ
show relatively weak occupancy at promoters in general. How-
ever, their binding is enhanced at broad promoters and Mediator
Fig. 6 Mediator complex and its interactors at promoters. a Predominant Gene Ontology terms for genes with broad H3k4me3 promoters and for active
genes nearest to SEs (SE genes) in NSCs. Numbers of genes in each category are indicated between brackets. b Overlap of genes with broad H3K4me3
promoters and SE genes in NSCs. Venn diagram with the two categories of genes, their overlap and their predominant Gene Ontology terms is shown.
Numbers of genes in each category are indicated between brackets. c Distribution of mRNA levels in NSCs of the different categories of active genes. Box
plots based on RNA-seq triplicate data are shown. Broad-SE, broad H3K4me3 promoter genes not nearest to SE. SE-Broad, SE genes without broad
H3K4me3 promoter. SE+ Broad, SE genes with broad H3K4me3 promoter. Typical, genes nearest to a typical enhancer but not nearest to an SE and
without a broad H3K4me3 promoter. mRNA levels of all genes and top 100 genes within each category are shown. Statistically signiﬁcant differences
between groups are indicated as separate letters above the box plots, as assessed by Student t-tests comparing all gene subsets (lower case letters) or top
100 subsets (upper case letters). p < 0.001 except for B, p < 0.05. If the letters are the same, the difference between these groups is not signiﬁcant. Source
data are provided as a Source Data ﬁle. d ChIP-seq density plots around promoters of the different categories of genes for the indicated factors and histone
modiﬁcations. Mean ChIP-seq density (y-axis) and distance to TSS (x-axis) are shown. e Overlap of binding sites of Med1 with binding sites of Mediator
interactors at the Trim8 broad H3K4me3 promotor area in NSCs. ChIP-seq tracks for the indicated proteins and histone modiﬁcations at the Trim8 gene are
shown. Range of reads per million per base pair is indicated on the y-axis. Scale bar is indicated
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follows closely their binding pattern in our genome-wide plots, as
well as at individual broad promoters. We ﬁnd that Mediator-
interacting chromatin modiﬁers, such as Carm1 and Jmjd1c, also
track Mediator binding at promoters. Relative enrichment of
transcription factors at broad promoters was observed before in
different cell types31,32. Our results suggest that broad promoters
may act like proximal enhancers in recruiting TFs, which in turn
can recruit Mediator and its interactors. The close resemblance of
the Mediator genome-wide binding sites with the binding sites of
its interacting TFs is highly suggestive of Mediator recruitment by
these TFs.
We ﬁnd that Tcf4 preferentially regulates SE-containing genes
in NSCs, including a set of neurogenic transcription factor genes
that have SEs and broad promoters. Intriguingly, we ﬁnd that a
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number of the TFs encoded by these genes have protein–protein
interactions with the Tcf4 protein. Some of these Tcf4-interacting
TFs colocalize with Tcf4 at SEs in this set of target genes, as well
as on the Tcf4 gene itself, suggesting a feed-forward circuit that
maintains the expression of these TFs in NSCs. Feed-forward
circuits of key TFs in embryonic stem cells (ESCs), such as Oct4,
Sox2, Nanog, Esrrb and Klf4, were shown to regulate plur-
ipotency and follow the same above criteria7,50,51. Analogous to
the ESC TF circuit, many of the TFs in our NSC circuit are
essential for NSC self-renewal or their neuronal differentiation
capacity. Together, this suggests that we have uncovered a TF
circuit that would be central to the regulation of NSC identity.
TCF4 heterozygosity in humans leads to Pitt Hopkins syndrome
with severe intellectual disability52,53, whereas SNPs in the TCF4
locus are the most signiﬁcant schizophrenia risk SNPs to date54.
These genetic data suggest that TCF4 plays an important role in
brain development and needs to be tightly regulated to prevent
neurodevelopmental disease. Our TF circuit may facilitate this
regulation.
Mediator complex binding signal was used as one parameter to
postulate SEs7, which were subsequently shown to regulate cell-
identity genes and oncogenes in many cell types7–9. More
recently, promoters with a broad H3K4me3 domain were pos-
tulated to regulate cell-identity genes31,32. As was shown before in
other cell types31,32, we ﬁnd that SE genes and Broad genes
partially overlap in NSCs. However, we show that the link to
neurogenic transcriptional regulators in SE genes and Broad
genes in NSCs is derived from neurogenic transcriptional reg-
ulator genes in the overlap of both categories; genes that have
both SEs and broad promoters. This suggests that, at least in
NSCs, SE+ Broad genes represent a special category of genes that
is strongly linked to cell identity. These SE+ Broad genes have
high recruitment of Mediator at their SEs (by deﬁnition) and we
ﬁnd that they also recruit high levels of Mediator to their pro-
moters. Increased promoter levels of Mediator are also observed
at broad promoters without surrounding SEs may therefore be
recruited by Mediator-interacting TFs, which we also ﬁnd enri-
ched at broad promoters. SEs were recently shown to have
increased 3D interactions with broad promoters, as compared to
typical promoters33. We ﬁnd that SE+ Broad genes in NSCs are
the category of genes with highest levels of RNApol2 and Inte-
grator at their promoters. Integrator complex associates with
RNApol2 and plays an important role in the transcription-
initiation and pause-release of RNApol230. The efﬁcient recruit-
ment of RNApol2 and Integrator at SE+ Broad genes thereby
provides an explanation for our observation that this category of
genes has the highest expression in NSCs.
All together this ﬁts into a model (Fig. 7h) where Mediator is
recruited by Mediator-interacting TFs to both SEs and Broad
promoters. These elements then form relatively stable enhancer-
promoter assemblies that have high local concentrations of
Mediator and its co-recruited protein–protein interaction part-
ners, including RNApol2, Integrator and chromatin modiﬁers.
Such assemblies would provide an optimal environment for the
efﬁcient pause-release of high quantities of RNApol2 and thereby
combine the high transcriptional consistency and the high tran-
scriptional efﬁciency that have been shown for broad promoters
and SE genes, respectively7,8,31. SE-broad promoter assemblies
and our identiﬁed Mediator interactions could provide ideal
building blocks for the phase-separated complexes that have been
recently proposed to drive robust transcription of cell-identity
genes in mammals14.
Methods
Puriﬁcation of the Mediator complex from neural stem cells. NS-5 neural stem
cells (NSCs) were derived from 46 C embryonic stem cells55 and cultured on
N2B27 medium (Stem Cell Sciences) supplemented with EGF and FGF (both from
Peprotech)56 and regularly tested for mycoplasma contamination. Essentially all
our NSCs express NSC markers Sox2 and Nestin (Supplementary Fig. 3a and b).
NSC lines with stable expression of C-terminally FLAG-tagged Med15 were created
by electroporation with pCAG promoter-driven plasmids containing Med15 cDNA
and puromycin selection for individual clones with moderate expression of the
tagged proteins, as compared to endogenous levels20,28. Nuclear extract was pre-
pared from NSCs expressing FLAG-Med15 and from control NSCs by the classical
Dignam protocol21 and FLAG-tagged Mediator complex was puriﬁed from 1.5 ml
nuclear extract, equivalent to 2 × 108 NSCs, by FLAG-afﬁnity puriﬁcation, and
analyzed by mass spectrometry, as described19,20. In brief, nuclear extracts were
dialyzed to 20 mM Hepes pH7.6, 0.2 mM EDTA, 1.5 mM MgCl2, 100 mM KCl,
20% glycerol (buffer C-100). Eighty microlitre of anti-Flag M2 agarose beads
(Sigma) equilibrated in buffer C-100 were added to 1.5 ml of nuclear extract and
incubated for 3 h at 4 °C in the presence of Benzonase (Novagen). Beads were
washed ﬁve times with buffer C-100 containing 0.02% NP-40 (C-100*) and bound
proteins were subsequently eluted at 4 °C with buffer C-100* containing 0.2 mg/ml
Flag-tripeptide (Sigma). Elutions were TCA precipitated, separated on a 10%
NuPAGE Bis-Tris gel (Invitrogen) and stained with Colloidal Coomassie (Biorad)
according to manufacturer’s instructions. Gel lanes were cut and subjected to in-gel
digestion with trypsin (Promega). Nano-LC-MS/MS was performed on an 11 series
capillary LC system (Agilent Technologies) coupled to an LTQ mass spectrometer
(Thermo). Peptide spectra from puriﬁed Mediator samples or control sample were
searched against UniProt release 2012-11 for protein identiﬁcation using
MASCOT.
Mediator complex puriﬁcations were performed from nuclear extract with
Benzonase (150 U per ml nuclear extract) added or Ethidium bromide (50 μg per
ml) added at the start of the 3-h incubation period of the anti-FLAG antibody
beads with the nuclear extract. Alternatively, Mediator complex puriﬁcation was
performed from untreated nuclear extract. In one experiment, Mediator complex
puriﬁcations were performed from nuclear extracts treated with Benzonase,
Ethidium bromide or untreated nuclear extract, together with a control puriﬁcation
from nuclear extract from control NSCs. In a second, independent, experiment,
Mediator complex was puriﬁed from nuclear extract treated with Benzonase,
together with a control puriﬁcation. Control puriﬁcations were from nuclear
extract treated with benzonase. All puriﬁcations are shown in Supplementary
Data 1. An uncropped image of the DNA gel of Fig. 1b can be found in
Supplementary Fig. 4a.
Initial inclusion criteria for Mediator-interacting proteins are as described19; (1)
A minimal Mascot score of 50, (2) At least ﬁve-fold enrichment by emPAI score in
Fig. 7 Tcf4 regulates neurogenic transcription factor genes with super enhancers and broad H3K4me3 promoters. a Tcf4 signal at enhancers ranked by
Med1 content. Tcf4 ChIP-seq read content is in green, enhancers ranked by Med1 ChIP-seq read content is in red. b Percentages of downregulated genes in
the different categories upon Tcf4 knock-down in NSCs. Percentages of down-regulated genes in all genes and top 100 genes within each category are
shown. Statistically signiﬁcant differences between groups are indicated as separate letters in the pie charts, p < 0.001 as assessed by Student t-tests.
c Changes in mRNA levels of the different categories of genes upon Tcf4 knock-down in NSCs. Log2 fold change, based on RNA-seq data, is shown. Error
bars indicate S.e.m., based on the RNA-seq triplicates. Statistically signiﬁcant differences between groups are indicated as separate letters below the box
plots, p < 0.001 as assessed by Student t-tests. Source data are provided as a Source Data ﬁle. d Percentage of Tcf4-bound SEs in SE+ Broad genes or SE-
Broad genes in NSCs. SEs nearest to SE+ Broad genes or SE-Broad genes with or without signiﬁcant Tcf4 binding sites, as determined by ChIP-seq, were
counted. e Model of Tcf4-driven feed-forward transcriptional circuit of SE+ Broad TF genes in NSCs. Fifteen15 SE+ Broad TF genes bound at their SE and
activated by Tcf4 are indicated. Tcf4 also binds its own SE. TF proteins encoded by six target genes also interact with Tcf4 protein and may aid in
transcriptional regulation by Tcf4. f, g Overlap of binding sites of Tcf4 and Med1 with Tcf4-interactors Olig2 and NFI at the Olig2 gene (f) or Tcf4 gene (g)
in NSCs. ChIP-seq tracks for the indicated proteins are shown. SE is indicated with a red bar. Range of reads per million per base pair is indicated on the y-
axis. Scale bar is indicated. h Model of SE-Broad H3K4me3 promoter assemblies. TFs at SE constituents and the Broad H3K4me3 promoter recruit high
levels of Mediator complex into SE-Broad assemblies. In turn, Mediator recruits high levels of protein–protein interaction partners such as the RNApol2
complex, Integrator, and chromatin modiﬁers. This would result in efﬁcient pause-release of RNApol2 and high but TF-regulated levels of transcription
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10502-8
12 NATURE COMMUNICATIONS |         (2019) 10:2669 | https://doi.org/10.1038/s41467-019-10502-8 | www.nature.com/naturecommunications
the Mediator puriﬁed sample over the control sample. emPAI score is an estimate
of the quantity of the identiﬁed protein in the puriﬁed protein sample, based on the
number of peptide spectra identiﬁed by MS, normalized for the number of peptides
that theoretically should be identiﬁable for that protein57. (3) At least three-fold
enrichment by Mascot score in the mediator puriﬁed sample over the control
sample. (4) Cytoskeletal and cytoplasmic proteins (Uniprot) were removed. Of
note, of the 96 identiﬁed Mediator complex interactors, only 12 are also detected in
any of the two control samples (Supplementary Data 1).
Subsequently, recorded Mediator interactors cannot be two-fold lower or more
in emPAI score in the Mediator complex puriﬁcation from puriﬁcations from
nuclear extracts treated with Benzonase or Ethidium bromide, as compared to a
parallel Mediator complex puriﬁcation from untreated nuclear extract. Finally,
Mediator interaction partners are only included in the ﬁnal list (Supplementary
Data 1) if they are speciﬁcally present in all four Mediator complex puriﬁcations.
Mediator interaction partners were deﬁned as novel if they did not appear as
identiﬁed by Afﬁnity Capture or Reconstituted Complex in BioGRID, the most
comprehensive protein–protein interaction database58. Interaction network
graphics were made with Cytoscape59. Thickness of the edges in the interaction
network (Fig. 1c) gives an indication of the relative molar protein quantity (based
on emPAI score) in puriﬁed Mediator complex samples with 4 categories of
thickness; emPAI > 1.5, thickest edge, 0.75 < emPAI ≤ 1.5, one but thickest edge,
0.25 < emPAI ≤ 0.75, one but thinnest edge, emPAI < 0.25, thinnest edge.
Immunoprecipitations. Immunoprecipitation of Med12 was performed from 1.5
ml of NSC nuclear extract using 15 μg Med12 antibody (Bethyl Laboratories
#A300-774A) crosslinked by dimethyl pimelimidate (Sigma) to 50 μl (pellet
volume) of protein G sepharose beads (GE17-0618-01, Sigma), as described19.
Med12 antibody beads were blocked with 0.1 mg/ml insulin (Sigma), 0.2 mg/ml
chicken egg albumin (Sigma), 1% ﬁsh skin gelatin (Sigma) and added to 1.5 ml of
nuclear extract with or without 225 units of Benzonase (Novagen) and rotated for
3 h at 4 °C in no-stick microcentrifuge tubes (Alpha Laboratories), washed ﬁve
times with 1 ml of C-100* buffer (20 mM Hepes pH 7.6, 0.2 mM EDTA, 1.5 mM
MgCl2, 100 mM KCl, 20% glycerol) at 4 °C and proteins eluted from the beads by
5 min at 95 °C in 50 μl SDS-loading dye. Eluted proteins were separated by poly-
acrylamide gelelectrophoresis and analyzed by mass spectrometry, as described
above. Inclusion criteria for endogenous Mediator interactors (Supplementary
Data 2) are as for the FLAG-Mediator puriﬁcation, except for the requirements on
emPAI score ratio in benzonase versus no benzonase samples. Immunoprecipita-
tions of Jmjd1c or Carm1 were performed from 1ml of NSC nuclear extract treated
with benzonase and using 10 μg of Jmjd1c antibody (Merck Millipore #17-10262),
or 10 μg Carm1 antibody (Cell Signaling Technology #12495) or 10 μg of control
rabbit IgG (Santa Cruz #sc-2027) were as described above but without mass
spectrometry analyses. Resulting western blots were performed with PBS 0.1%
Tween solutions, blocking in 5% Fat-free milk proteins and probing with Jmjd1c
antibody (Merck Millipore #17-10262, 1:1000), Med12 antibody (Bethyl Labora-
tories #A300-774A, 1:1000) and Donkey anti-rabbit HRP-conjugates (Sigma
#GENA934, 1:2500). Uncropped images of the westerns are found in Supple-
mentary Fig. 4b–e.
Mediator-interacting TFs. References for function in neural development. Yy160,
Nﬁa61, Sox262, Nﬁb63, Sall331, Tcf1264, Znf2465, Rela66, Tcf467,68. TF mRNA levels
in our NSCs are from our RNA-seq data on our wild-type NSCs28.
ChIP-seq. We adapted protocols previously described7,28. 1.5 × 108 NSCs were
used per chromatin immunoprecipitation (ChIP). Cells were collected in 1xPBS
and crosslinked ﬁrst with 2 mM disuccinimidyl glutarate (Thermo Fisher Scientiﬁc,
Waltham, MA, USA) solution for 45 min and then 1% formaldehyde solution for
15 min at room temperature. Cells were washed twice with 1X PBS and ﬂash frozen
in liquid nitrogen. Chromatin was prepared for sonication with 20 mM Tris-HCl
pH8, 150 mM NaCl, 2 mM EDTA, 0.1% SDS, 1% Triton X-100. We used 15 cycles
of 30 s ON, 30 s OFF on a Bioruptor Pico sonication device (Diagenode Cat#
B01060001) to shear chromatin to 150–200 bp fragments. The resulting 300 µg of
chromatin extract was incubated overnight at 4 °C with 100ul of Dynal Protein G
magnetic beads that had been pre-incubated with 10 μg of the appropriate anti-
body. We used the following antibodies: Med1 (Bethyl Labs #A300-793A), Carm1
(Cell Signaling Technology #12495), Jmjd1c (Merck Millipore #17-10262), IgG
(Normal Rabbit IgG: Santa Cruz #sc-2027). Beads were washed 1X with the
sonication buffer, 1X with 20 mM Tris-HCl pH8, 500 mM NaCl, 2 mM EDTA,
0.1% SDS, 1%Triton X-100, 1X with 10 mM Tris-HCl pH8, 250 mM LiCl, 2 mM
EDTA, 1% NP40 and 1X with TE containing 50 mM NaCl. Bound complexes were
eluted from the beads in 50 mM Tris-HCl, pH 8.0, 10 mM EDTA and 1% SDS by
heating at 65 °C for 1 hr with occasional vortexing and crosslinking was reversed by
overnight incubation at 65 °C. ChIP-seq sample preparation and sequencing on
Illumina GAII or HiSeq2500 (San Diego, CA, USA) platforms was performed at the
Erasmus MC Center for Biomics, according to manufacturer’s instructions.
ChIP in combination with knock-down. For Tcf4 knock-down, 36 transfections of
each 3.5 μg of pSuper-puro-Tcf4-shRNA#128 into 3.5 × 106 NSCs (in total 126 ×
106 NSCs were transfected) were performed using program A-33 on the Amaxa
nucleofector I, kit Cell Line Nucleofector™ Kit V (Lonza, catalog # VVCA-1003)
and plated on 36 6-cm dishes. As control, pSuper-puro-Control-shRNA transfec-
tions were performed with the same set-up. Control (scrambled control sequence
from Dharmacon) shRNA sequence: GGTGAGCTTCATGAGGATG. Selection
was started 20 h after transfection with 2 µg/ml Puromycin and NSCs were col-
lected after 28 h of selection (48 h after transfection). For Sox2 knock-down, 36
transfection of pSuper-puro-Sox2-shRNA#120 into NSCs were performed using the
same set-up as for Tcf4. As control, pSuper-puro-Control-shRNA transfections
were performed with the same set-up. Selection was started 18 h after transfection
with 2 µg/ml Puromycin and cells were harvested after 28 h of selection (46 h after
transfection). Before crosslinking the NSCs, one 6-cm dish for each shRNA con-
struct was collected to verify the gene expression of Tcf4 and Sox2 by qRT-PCR.
RNA was isolated using the GenElute™ Mammalian Total RNA Miniprep Kit
(Sigma, RTN350-1KT) and reverted to cDNA using RevertAid First Strand cDNA
Synthesis Kit (Fermentas, K1621).
ChIP was performed as described above on 30 µg of chromatin per condition
with 30 µl of Dyna Protein G beads pre-incubated with either 3 µg of Med12
antibody (Bethyl Laboratories #A300-774A) or 3 µg rabbit IgG (Santa Cruz #sc-
2027) for control ChIPs. Tcf4 knock-down ChIPs, Sox2 knock-down ChIPs and
their respective control ChIPs were performed in biological duplicate. RT-PCR was
performed on genomic targets indicated with their distance from the TSS of the
nearest gene with—indicating upstream of the TSS and +indicating downstream of
the TSS. Supplementary Table 2 lists all used primers.
Immunocytochemistry. Neural stem cells were grown on poly-D-lysine (0.5 mg/
ml, Sigma–Aldrich) coated glass coverslips and ﬁxed in 4% Paraformaldehyde for
10 min at room temperature. After ﬁxation, the cells were washed with PBS+ (0.5%
Bovine Serum Albumin and 0.15% Glycine in PBS) and permeabilized with PBS-
0.1% Triton X-100. Subsequently, slides were incubated with the primary anti-
bodies (Rabbit anti-Nestin, Biolegend® 839801, 1:200 dilution, and goat anti-Sox2,
Santa-Cruz Biotechnology sc-17320, 1:200 dilution) diluted in PBS+ for 2 h at
room temperature. After subsequent washes with PBS-0.1% Triton X-100 and with
PBS+, the coverslips were incubated with secondary antibodies (Donkey anti-
Rabbit Alexaﬂuor 488 and Donkey anti-Goat Alexaﬂuor 594) diluted in PBS+ and
washed with PBS-0.1% Triton X-100 and PBS+. The samples were mounted with
MOWIOL (#324590, Sigma–Aldrich) and nuclei were stained with DAPI (Vector
laboratories). Images were captured using a Leica DM4000 B ﬂuorescent micro-
scope and image processing was performed using FIJI (ImageJ). Sox2-positive
NSCs or Nestin-positive NSCs were counted.
Genomic data analyses. All ChIP-seq datasets were mapped to the mouse mm9
reference genome using Bowtie v0.12.769, where we used a seed length of 36 in
which we allowed a maximum of two mismatches. If a read had multiple align-
ments only the best matching read was reported. ChIP-seq datasets with multiple
replicates were merged. Duplicated reads were removed. MACS46 v1.4.2 was used
for peak calling using default settings, using IgG ChIP-seq as background control
for our Med1, Carm1, Jmjd1c, Tcf4, Olig2 and Chd7 ChIP-seq data. For external
ChIP-seq datasets either IgG ChIP-seq or sequenced chromatin input was used as
background control. For histone modiﬁcations we used HOMER ﬁndPeaks70 using
-region -size 1000 -minDist 2500 parameters. Genomic datasets that are generated
and/or used in this study are summarized in Supplementary Table 1.
Enhancers in mouse NSCs were deﬁned by recalling Ep300 and H3K27ac peaks
using HOMER, function REGION, and using Bedtools71 to generate overlaps
between Ep300 peaks and H3K27ac peaks. SEs were identiﬁed using the ROSE
algorithm7. ROSE stitches together enhancers that are within 12.5 kb of each other
and do not overlap with a window of 1 kb on either side of a TSS and ranks such
combined enhancers by their total Med1 ChIP-seq signal7. Four hundred forty-ﬁve
super enhancers were identiﬁed and the rest were assigned as typical enhancers.
Plotting was performed using hockey function in R We used the already described
list of mouse NSCs broad H3K4me3 promoters31.
For mRNA levels in our mouse NSCs, we used our published RNA sequencing
dataset28 consisting of three replicates to calculate the mean mRNA expression
levels. Super enhancer (SE) genes and typical enhancer genes are deﬁned as the
closest active gene, RKPM > 0.5 in our NSC RNA-seq data28, to an SE or a typical
enhancer, respectively.
Motif analyses were performed using HOMER70 and selecting the most
frequent motifs found at Med1 binding sites at SE constituents and typical
enhancers.
For genome-wide binding site overlaps, we used the 5000 most signiﬁcant
binding sites for each factor to determine the percentage of overlap between two
factors. Two binding sites were considered overlapping if their summits were
within 200 bp. Promoters were deﬁned as the regions within 1.5 kb of a
transcription start site (TSS). Top 5000 peaks from Mediator and its interactors
were separated in the TSS, non TSS, typical enhancer and super enhancer
categories and the percentage of overlap recalculated for each subset.
Generation of histograms documenting ChIP-seq signal density at speciﬁc sets
of promoters in the NSC genome was performed by HOMER annotatePeaks with
10 bp bins and 12,000 bp around the TSS. By default, HOMER normalizes the
output histogram such that the resulting units are per bp per peak, on top of the
standard total mapped tag normalization of 10 million tags. For each promoter,
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directionality was extracted from TSS annotation and each subset was split between
plus or minus strand. Subsequently, split lists were then remerged taking into
account directionality to ﬁnally calculate the ChIP-signal density values. Enhancer-
annotated expressed genes not present on the super enhancer gene list or the broad
H3K4me3 promoter gene list were used as typical genes.
Gene Ontology analyses on the different gene categories were performed using
DAVID version 6.772 using default categories. SE genes are deﬁned as the closest
active gene, RKPM > 0.5 in our NSC RNA-seq data28, to an SE. Broad H3K4me3
genes are deﬁned as having the top 5% broadest H3K4me3 domains31.
Additionally, we performed GO ontology biological process analysis of the
transcription regulators found in each subset. Benjamini-corrected p-value was
used for ranking Gene Ontology terms.
Top 100 SE+ Broad genes are genes with a broad promoter and from that
category the 100 genes that are the nearest gene to the highest SEs (i.e. one gene per
SE), as ranked by Mediator signal. Top 100 SE-Broad genes are genes without a
broad promoter and from that category the 100 genes that are the nearest gene to
the highest SEs, as ranked by Mediator signal. Top 100 Broad-SE genes are genes
that not the nearest gene to an SE and from that category the 100 genes ranked by
the broadest H3K4me3 signal at their promoter, from an already described list of
mouse NSC broad H3K4me3 promoters31
Tcf4-regulated genes were derived from an RNA-seq. experiment performed in
triplicate 48 h after Tcf4-shRNA-transfection or control shRNA-transfection in
mouse NSCs28. Gene expression values with signiﬁcant triplicates were assigned to
the different subsets. The effect of Tcf4 knock-down was indicated by plotting the
mean fold change vs the scrambled shRNA condition for each subset.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The genomic data reported in this paper were submitted to GEO database under
accession number: GSE109043. The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium via the PRIDE partner73 repository with
the dataset identiﬁer PXD013546. Fig. 1c and Supplementary Data 1–3 have associated
proteomic data. Figs. 2d, 3, 4, 6 and 7, Supplementary Figs. 1 and 2, Supplementary
Data 4 and 5 have associated genomic data. The source data underlying Figs. 1b, 2a, b, 3a,
c, 5a–d, 6c, 7c are provided as a Source Data ﬁle. All other relevant data supporting the
key ﬁndings of this study are available within the article and its Supplementary
Information ﬁles or from the corresponding author upon reasonable request. A reporting
summary for this Article is available as a Supplementary Information ﬁle.
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